{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:38:07Z","timestamp":1787236687690,"version":"build-2736575974"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012264","name":"NIH","doi-asserted-by":"publisher","award":["DK32333)"],"award-info":[{"award-number":["DK32333)"]}],"id":[{"id":"10.13039\/501100012264","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.maturitas.2020.04.006","type":"journal-article","created":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T11:08:20Z","timestamp":1586776100000},"page":"49-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Non-surgical management of primary hyperparathyroidism in the aging population"],"prefix":"10.1016","volume":"136","author":[{"given":"Cristiana","family":"Cipriani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Bilezikian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10116","key":"10.1016\/j.maturitas.2020.04.006_bib0005","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0140-6736(17)31430-7","article-title":"Hyperparathyroidism","volume":"391","author":"Bilezikian","year":"2018","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.maturitas.2020.04.006_bib0010","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1210\/jc.2012-4022","article-title":"Incidence and prevalence of primary hyperparathyroidism in a racially mixed population","volume":"98","author":"Yeh","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.maturitas.2020.04.006_bib0015","first-page":"A4567","article-title":"Increasing incidence of primary hyperparathyroidism in Denmark","volume":"60","author":"Abood","year":"2013","journal-title":"Dan. Med. J."},{"key":"10.1016\/j.maturitas.2020.04.006_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bone.2014.12.003","article-title":"Secular trends in the incidence of primary hyperparathyroidism over five decades (1965-2010)","volume":"73","author":"Griebeler","year":"2015","journal-title":"Bone"},{"issue":"10","key":"10.1016\/j.maturitas.2020.04.006_bib0025","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1210\/jc.2014-1413","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop","volume":"99","author":"Bilezikian","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.maturitas.2020.04.006_bib0030","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1210\/jc.2014-1417","article-title":"Medical management of primary hyperparathyroidism: proceedings of the fourth International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism","volume":"99","author":"Marcocci","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.maturitas.2020.04.006_bib0035","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1007\/s00268-018-4629-3","article-title":"Patient frailty should Be used to individualize treatment decisions in primary hyperparathyroidism","volume":"42","author":"Seib","year":"2018","journal-title":"World J. Surg."},{"issue":"4","key":"10.1016\/j.maturitas.2020.04.006_bib0040","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1210\/jc.2014-3708","article-title":"Prevalence of kidney stones and vertebral fractures in primary hyperparathyroidism using imaging technology","volume":"100","author":"Cipriani","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.maturitas.2020.04.006_bib0045","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1210\/jc.2017-01080","article-title":"Sex difference in the clinical presentation of primary hyperparathyroidism: influence of menopausal status","volume":"102","author":"Castellano","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.maturitas.2020.04.006_bib0050","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1210\/jc.2016-1513","article-title":"Forearm DXA increases the rate of patients with asymptomatic primary hyperparathyroidism meeting surgical criteria","volume":"101","author":"Castellano","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.maturitas.2020.04.006_bib0055","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00268-002-6589-9","article-title":"Fractures in patients with primary hyperparathyroidism: nationwide follow-up study of 1201 patients","volume":"27","author":"Vestergaard","year":"2003","journal-title":"World J. Surg."},{"issue":"9","key":"10.1016\/j.maturitas.2020.04.006_bib0060","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1002\/jbmr.3461","article-title":"Prevalence and risk of vertebral fractures in primary hyperparathyroidism: a nested case-control study","volume":"33","author":"Ejlsmark-Svensson","year":"2018","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"10.1016\/j.maturitas.2020.04.006_bib0065","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1210\/jc.2013-4192","article-title":"Predictors of renal function in primary hyperparathyroidism","volume":"99","author":"Walker","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.maturitas.2020.04.006_bib0070","doi-asserted-by":"crossref","first-page":"R39","DOI":"10.1530\/EJE-16-0430","article-title":"Mechanisms in endocrinology: kidney involvement in patients with primary hyperparathyroidism: an update on clinical and molecular aspects","volume":"176","author":"Verdelli","year":"2017","journal-title":"Eur. J. Endocrinol."},{"issue":"4","key":"10.1016\/j.maturitas.2020.04.006_bib0075","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1530\/EJE-15-0341","article-title":"Estimated glomerular filtration rate by serum cystatin C correlates with cardiometabolic parameters in patients with primary hyperparathyroidism","volume":"173","author":"Ermetici","year":"2015","journal-title":"Eur. J. Endocrinol."},{"issue":"9","key":"10.1016\/j.maturitas.2020.04.006_bib0080","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1210\/jc.2018-00923","article-title":"Predictors of renal function and calcifications in primary hyperparathyroidism: a nested case-control study","volume":"103","author":"Ejlsmark-Svensson","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.maturitas.2020.04.006_bib0085","doi-asserted-by":"crossref","DOI":"10.1111\/cen.14064","article-title":"Investigating subtle kidney injury in primary hyperparathyroidism by means of sensitive and specific biomarkers","author":"Cipriani","year":"2019","journal-title":"Clin. Endocrinol."},{"issue":"6","key":"10.1016\/j.maturitas.2020.04.006_bib0090","first-page":"805","article-title":"Non classical complications of primary hyperparathyroidism, best practice & research","volume":"32","author":"Chiodini","year":"2018","journal-title":"Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.maturitas.2020.04.006_bib0095","doi-asserted-by":"crossref","first-page":"R297","DOI":"10.1530\/EJE-17-0485","article-title":"Cardiovascular manifestations of primary hyperparathyroidism: a narrative review","volume":"177","author":"Pepe","year":"2017","journal-title":"Eur. J. Endocrinol."},{"issue":"11","key":"10.1016\/j.maturitas.2020.04.006_bib0100","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/hed.20887","article-title":"Comparison of perioperative management and outcome of parathyroidectomy between older and younger patients","volume":"30","author":"Bachar","year":"2008","journal-title":"Head Neck"},{"issue":"13","key":"10.1016\/j.maturitas.2020.04.006_bib0105","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1245\/s10434-013-3187-z","article-title":"Presentation, management, and outcomes of hyperparathyroidism in octogenarians and nonagenarians","volume":"20","author":"Oltmann","year":"2013","journal-title":"Ann. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.maturitas.2020.04.006_bib0110","doi-asserted-by":"crossref","first-page":"74","DOI":"10.5694\/j.1326-5377.1988.tb120508.x","article-title":"Neuromuscular symptoms in elderly patients with hyperparathyroidism: improvement with parathyroid surgery","volume":"149","author":"Delbridge","year":"1988","journal-title":"Med. J. Aust."},{"issue":"4","key":"10.1016\/j.maturitas.2020.04.006_bib0115","doi-asserted-by":"crossref","first-page":"450","DOI":"10.4158\/EP11206.OR","article-title":"Greater than age-predicted functional deficits in older patients with primary hyperparathyroidism","volume":"18","author":"Morris","year":"2012","journal-title":"Endocr. Pract."},{"issue":"3","key":"10.1016\/j.maturitas.2020.04.006_bib0120","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1507\/endocrj.K06-152","article-title":"Marked improvement of psychiatric symptoms after parathyroidectomy in elderly primary hyperparathyroidism","volume":"54","author":"Chiba","year":"2007","journal-title":"Endocr. J."},{"issue":"2","key":"10.1016\/j.maturitas.2020.04.006_bib0125","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/ggi.12526","article-title":"Hypercalcemia secondary to primary hyperparathyroidism: a curable cause of cognitive decline in the elderly not to be neglected","volume":"16","author":"Foppiani","year":"2016","journal-title":"Geriatr. Gerontol. Int."},{"issue":"6","key":"10.1016\/j.maturitas.2020.04.006_bib0130","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1210\/jc.2008-2574","article-title":"Neuropsychological features in primary hyperparathyroidism: a prospective study","volume":"94","author":"Walker","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.maturitas.2020.04.006_bib0135","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1176\/appi.psy.43.5.413","article-title":"New onset of neuropsychiatric symptoms in the elderly: possible primary hyperparathyroidism","volume":"43","author":"Watson","year":"2002","journal-title":"Psychosomatics"},{"issue":"1","key":"10.1016\/j.maturitas.2020.04.006_bib0140","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1677\/erc.1.01261","article-title":"The association between primary hyperparathyroidism and malignancy: nationwide cohort analysis on cancer incidence after parathyroidectomy","volume":"14","author":"Nilsson","year":"2007","journal-title":"Endocr. Relat. Cancer"},{"issue":"11","key":"10.1016\/j.maturitas.2020.04.006_bib0145","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1245\/s10434-014-3731-5","article-title":"Quality of life is modestly improved in older patients with mild primary hyperparathyroidism postoperatively: results of a prospective multicenter study","volume":"21","author":"Blanchard","year":"2014","journal-title":"Ann. Surg. Oncol."},{"issue":"10","key":"10.1016\/j.maturitas.2020.04.006_bib0150","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S2213-8587(19)30188-3","article-title":"Three generational phenotypes of sporadic primary hyperparathyroidism: evolution defined by technology","volume":"7","author":"Cipriani","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"4","key":"10.1016\/j.maturitas.2020.04.006_bib0155","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa084","article-title":"Normocalcemic Hyperparathyroidism: Study of its Prevalence and Natural History","volume":"105","author":"Schini","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.maturitas.2020.04.006_bib0160","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1210\/jc.2014-1414","article-title":"Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop","volume":"99","author":"Eastell","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.maturitas.2020.04.006_bib0165","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1055\/a-0752-4533","article-title":"Normocalcemic primary hyperparathyroidism: a comparison with the hypercalcemic form in a tertiary referral population","volume":"50","author":"Pierreux","year":"2018","journal-title":"Horm. Metab. Res."},{"issue":"6","key":"10.1016\/j.maturitas.2020.04.006_bib0170","first-page":"837","article-title":"Management of normocalcemic primary hyperparathyroidism, best practice & research","volume":"32","author":"Cusano","year":"2018","journal-title":"Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.maturitas.2020.04.006_bib0175","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s12020-016-1101-8","article-title":"Skeletal changes after restoration of the euparathyroid state in patients with hypoparathyroidism and primary hyperparathyroidism","volume":"55","author":"Cipriani","year":"2017","journal-title":"Endocrine"},{"issue":"7261","key":"10.1016\/j.maturitas.2020.04.006_bib0180","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1136\/bmj.321.7261.598","article-title":"Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism","volume":"321","author":"Vestergaard","year":"2000","journal-title":"Bmj"},{"issue":"2","key":"10.1016\/j.maturitas.2020.04.006_bib0185","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jss.2007.01.027","article-title":"Parathyroidectomy for primary hyperparathyroidism in octogenarians and nonagenarians: a risk-benefit analysis","volume":"140","author":"Egan","year":"2007","journal-title":"J. Surg. Res."},{"issue":"9","key":"10.1016\/j.maturitas.2020.04.006_bib0190","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1111\/jgs.12968","article-title":"Surgical management of primary hyperparathyroidism in older adults","volume":"62","author":"Denizot","year":"2014","journal-title":"J. Am. Geriatr. Soc."},{"issue":"9","key":"10.1016\/j.maturitas.2020.04.006_bib0195","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1210\/jc.2009-2819","article-title":"Underutilization of parathyroidectomy in elderly patients with primary hyperparathyroidism","volume":"95","author":"Wu","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.maturitas.2020.04.006_bib0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161192","article-title":"Declining rates of inpatient parathyroidectomy for primary hyperparathyroidism in the US","volume":"11","author":"Kim","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.maturitas.2020.04.006_bib0205","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.ando.2015.10.006","article-title":"Hyperparathyroidism in octogenarians: a plea for ambulatory minimally invasive surgery under local anesthesia","volume":"77","author":"Fui","year":"2016","journal-title":"Annales D\u2019endocrinologie"},{"issue":"6","key":"10.1016\/j.maturitas.2020.04.006_bib0210","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.jamcollsurg.2009.01.048","article-title":"Outpatient minimally invasive parathyroidectomy is safe for elderly patients","volume":"208","author":"Shin","year":"2009","journal-title":"J. Am. Coll. Surg."},{"issue":"4","key":"10.1016\/j.maturitas.2020.04.006_bib0215","first-page":"381","article-title":"Risk Factors for Intraoperative Hypertension during Surgery for Primary Hyperparathyroidism, Medical principles and practice\u202f: international journal of the Kuwait University","volume":"26","author":"Sabljak","year":"2017","journal-title":"Health Sci. Centre"},{"issue":"2","key":"10.1016\/j.maturitas.2020.04.006_bib0220","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jss.2011.03.014","article-title":"Parathyroidectomy in the elderly: analysis of 7313 patients","volume":"170","author":"Thomas","year":"2011","journal-title":"J. Surg. Res."},{"issue":"2","key":"10.1016\/j.maturitas.2020.04.006_bib0225","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s00268-019-05280-9","article-title":"Parathyroidectomy is safe in elderly patients: a national surgical quality improvement program study","volume":"44","author":"Khokar","year":"2020","journal-title":"World J. Surg."},{"issue":"12","key":"10.1016\/j.maturitas.2020.04.006_bib0230","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1007\/s00198-016-3715-3","article-title":"Comparative efficacy of parathyroidectomy and active surveillance in patients with mild primary hyperparathyroidism: a systematic review and meta-analysis","volume":"27","author":"Singh Ospina","year":"2016","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.maturitas.2020.04.006_bib0235","article-title":"Therapeutic challenges for elderly patients with primary hyperparathyroidism","volume":"2019","author":"Sluis","year":"2019","journal-title":"Case Rep. Endocrinol."},{"key":"10.1016\/j.maturitas.2020.04.006_bib0240","series-title":"Dietary Reference InTakes for Calcium and Vitamin D","author":"Ross","year":"2011"},{"issue":"9","key":"10.1016\/j.maturitas.2020.04.006_bib0245","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1210\/jc.2015-2022","article-title":"Vitamin d in primary hyperparathyroidism: effects on clinical, biochemical, and densitometric presentation","volume":"100","author":"Walker","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.maturitas.2020.04.006_bib0250","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.1210\/jc.2018-01225","article-title":"Primary hyperparathyroidism","volume":"103","author":"Bilezikian","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.maturitas.2020.04.006_bib0255","first-page":"821","article-title":"Non-surgical management of primary hyperparathyroidism, best practice & research","volume":"32","author":"Cetani","year":"2018","journal-title":"Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.maturitas.2020.04.006_bib0260","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women\u2019s Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.maturitas.2020.04.006_bib0265","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1210\/jc.2002-020667","article-title":"Raloxifene lowers serum calcium and markers of bone turnover in postmenopausal women with primary hyperparathyroidism","volume":"88","author":"Rubin","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.maturitas.2020.04.006_bib0270","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1359\/jbmr.2001.16.1.113","article-title":"Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism","volume":"16","author":"Rossini","year":"2001","journal-title":"J. Bone Miner. Res."},{"issue":"7","key":"10.1016\/j.maturitas.2020.04.006_bib0275","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1210\/jc.2003-030908","article-title":"Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial","volume":"89","author":"Khan","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.maturitas.2020.04.006_bib0280","doi-asserted-by":"crossref","first-page":"705","DOI":"10.4158\/EP08178.ORR","article-title":"Alendronate therapy in men with primary hyperparathyroidism","volume":"15","author":"Khan","year":"2009","journal-title":"Endocr. Pract."},{"issue":"2","key":"10.1016\/j.maturitas.2020.04.006_bib0285","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00774-013-0473-6","article-title":"Effect of parathyroidectomy versus risedronate on volumetric bone mineral density and bone geometry at the tibia in postmenopausal women with primary hyperparathyroidism","volume":"32","author":"Tournis","year":"2014","journal-title":"J. Bone Miner. Metab."},{"issue":"3","key":"10.1016\/j.maturitas.2020.04.006_bib0290","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/jgs.15250","article-title":"Protective effect of denosumab on bone in older women with primary hyperparathyroidism","volume":"66","author":"Eller-Vainicher","year":"2018","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.maturitas.2020.04.006_bib0295","series-title":"Drugs Acting on the Calcium Receptor: Calcimimetics and Calcilytics, Principles of Bone Biology","first-page":"1","author":"Cipriani","year":"2019"},{"issue":"5","key":"10.1016\/j.maturitas.2020.04.006_bib0300","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1530\/EJE-14-0877","article-title":"Cinacalcet normalizes serum calcium in a double-blind randomized, placebo-controlled study in patients with primary hyperparathyroidism with contraindications to surgery","volume":"172","author":"Khan","year":"2015","journal-title":"Eur. J. Endocrinol."},{"issue":"8","key":"10.1016\/j.maturitas.2020.04.006_bib0305","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1210\/jc.2008-2640","article-title":"Cinacalcet reduces serum calcium concentrations in patients with intractable primary hyperparathyroidism","volume":"94","author":"Marcocci","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.maturitas.2020.04.006_bib0310","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1210\/jc.2004-0842","article-title":"Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism","volume":"90","author":"Peacock","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.maturitas.2020.04.006_bib0315","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.1210\/jc.2010-1221","article-title":"Cinacalcet HCl reduces hypercalcemia in primary hyperparathyroidism across a wide spectrum of disease severity","volume":"96","author":"Peacock","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.maturitas.2020.04.006_bib0320","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s12020-011-9459-0","article-title":"Cinacalcet hydrochloride in combination with alendronate normalizes hypercalcemia and improves bone mineral density in patients with primary hyperparathyroidism","volume":"39","author":"Faggiano","year":"2011","journal-title":"Endocrine"},{"issue":"2","key":"10.1016\/j.maturitas.2020.04.006_bib0325","first-page":"123","article-title":"Effect of gender and geographic location on the expression of primary hyperparathyroidism","volume":"36","author":"De Lucia","year":"2013","journal-title":"J. Endocrinol. Invest."}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037851222030236X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037851222030236X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:16:23Z","timestamp":1759914983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037851222030236X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":65,"alternative-id":["S037851222030236X"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2020.04.006","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-surgical management of primary hyperparathyroidism in the aging population","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2020.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}